- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00166933
Minimal Erythema Dose of UV-B in Normal Population of Taiwan
December 20, 2005 updated by: National Taiwan University Hospital
There is no previous study on the minimal erythema dose of UVB irradiation in Chinese people.
We will investigate the correlation of skin phototype, constitutive skin color, facultative skin color and minimal erythema dose in Taiwanese.
Study Overview
Status
Completed
Conditions
Detailed Description
The skin phototype will be obtained from a structuralized questionaire.
The constitutive skin color and facultative skin color will be obtained by chromameter.
The minimal erythema dose will be obtained by physician's assessment.
Study Type
Observational
Enrollment
60
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Taipei, Taiwan, 100
- Chia-Yu Chu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
10 years to 65 years (Child, Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
10-65 years old normal healthy volunteers
Exclusion Criteria:
Age under 10 years old or older than 65 years old People with a past history of photo-sensitivity People who had been treated with phototherapy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Chia-Yu Chu, MD, Department of Dermatology, National Taiwan University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2005
Study Completion
August 1, 2005
Study Registration Dates
First Submitted
September 12, 2005
First Submitted That Met QC Criteria
September 12, 2005
First Posted (Estimate)
September 14, 2005
Study Record Updates
Last Update Posted (Estimate)
December 21, 2005
Last Update Submitted That Met QC Criteria
December 20, 2005
Last Verified
August 1, 2005
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 9461700530
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Human Volunteers
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
PfizerCompleted
-
Bispebjerg HospitalCompleted
-
PfizerCompletedHuman VolunteersUnited States
-
Tibotec Pharmaceuticals, IrelandCompleted
-
Universal EnterprisesUnknown
-
PfizerCompletedHuman VolunteersSingapore